Skip to content

Privately held Italian chemical-pharmaceutical company and parent of the ACS GROUP, focused on anti-infective solutions.

Last updated September 15, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

ACS DOBFAR is a privately held Italian chemical-pharmaceutical company established in 1973, with over 50 years of experience. Headquartered in Tribiano, about 10 km outside Milan, it operates 11 production facilities across Italy plus administrative offices near its headquarters. It is the parent company of the ACS GROUP, which operates 20 production facilities and 7 distribution centers across four continents and employs more than 3,500 people. As a fully integrated provider, it supplies pharmaceutical intermediates, APIs, and finished dosage forms (FDFs) to over 100 countries. Its mission is to deliver innovative anti-infective solutions combining research, development, and manufacturing services.

History

ACS DOBFAR was established in 1973 and describes itself as having over 50 years of Italian excellence in pharmaceuticals. It is a privately held Italian chemical-pharmaceutical company headquartered in Tribiano, about 10 km outside Milan, operating 11 production facilities across Italy with administrative offices near its headquarters. It is the parent company of the ACS GROUP, which operates 20 production facilities and 7 distribution centers across four continents and employs more than 3,500 people. The company states it is approved by AIFA and the FDA and maintains a robust R&D division.

Products and positioning

Fully integrated provider of affordable, high-quality pharmaceutical intermediates, APIs, and finished dosage forms; leading position in the healthcare sector.

  • Pharmaceutical intermediates

  • APIs

  • Finished dosage forms (FDFs)

  • Anti-infective products

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/acs-dobfar · Editorial policy · How profiles are compiled